Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04ZLG
|
||||
Former ID |
DIB003353
|
||||
Drug Name |
IDEC-151
|
||||
Synonyms |
Clenoliximab
|
||||
Drug Type |
Antibody
|
||||
Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Discontinued in Phase 2 | [546305] | ||
Company |
Biogen Idec
|
||||
Target and Pathway | |||||
Target(s) | T-cell surface glycoprotein CD4 | Target Info | [525728] | ||
NetPath Pathway | Leptin Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.